“…Numerous ML methods have been used to classify and predict AD stages with promising results (Haller, Lövblad et al 2011, Falahati, Westman et al 2014, Rathore, Habes et al 2017. While some studies have made use of a single screening modality, such as MRI (Fan, Batmanghelich et al 2008, Kloppel, Stonnington et al 2008, Cuingnet, Gerardin et al 2011, Liu, Zhang et al 2012, Tong, Wolz et al 2014, or electroencephalography (EEG) (Blinowska, Rakowski et al 2017, Farina, Emek-Savaş et al 2020, Ferri, Babiloni et al 2020, Oltu, Akşahin et al 2021, others have used a combination of multiple imaging techniques including MRI, PET, and cerebrospinal fluid (CSF) biomarkers (Zhang, Wang et al 2011, Gray, Aljabar et al 2013, Jie, Zhang et al 2013, Young, Modat et al 2013, Teipel, Kurth et al 2015, Yun, Kwak et al 2015, Samper-González, Burgos et al 2018. Although many of those studies presented interesting and promising results in AD classification, most focused on a so-called two-class problem.…”